MARCH 05, 2019 MINNEAPOLIS, March 5, 2019 /PRNewswire/ — Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, was honored with three prestigious 2019 CiteAb Awards. The CiteAb Awards celebrate the very best suppliers and individuals in the research sector worldwide. Bio-Techne’s Advanced Cell Diagnostics (ACD) brand received... Read more
Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Platform San Diego, Calif. – March 5, 2019 – Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced... Read more
Indianapolis, Indiana (February 28, 2019) – At the Advances in Genome Biology and Technology (AGBT) General Meeting*, Beckman Coulter Life Sciences announces the launch of Apostle MiniMax™ High Efficiency Cell-Free DNA Isolation Kit through an exclusive partnership with Apostle, a liquid biopsy company. As cfDNA workflows move beyond theoretical and into human health applications, Apostle’s industry leading chemistry... Read more
FEBRUARY 26, 2019 MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. Liwen Pei, Managing Director of Bio-Techne China, and Ning Zhou, CEO of Lisen, attended the meeting and signing ceremony. Bio-Techne is a leading provider of high-quality... Read more
Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech Agreement ensures consistent supply of nucleotides, enzymes and other critical raw materials for messenger RNA (mRNA) vaccine manufacturing platform WALTHAM, Mass., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today announced it has signed a multi-year agreement with Mainz,... Read more
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan Companion diagnostic test enables physicians to identify non-small cell lung cancer patients who may benefit from eight targeted therapies CARLSBAD, Calif., Feb. 26, 2019 /PRNewswire/ — Thermo Fisher Scientific today announced that the Ministry of Health, Labour and Welfare (MHLW), Japan’s regulatory agency,... Read more
Basel, 25 February 2019 Roche enters into definitive merger agreement to acquire Spark Therapeutics Roche to acquire Spark Therapeutics for US$ 114.50 per share Spark Therapeutics is a leader in discovering, developing and delivering gene therapies with one commercial asset and four programmes currently in clinical trials Transaction expected to close in Q2, 2019 Roche... Read more
Date: 02/14/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug... Read more
Orlando – Feb. 12, 2019 – GE Healthcare (NYSE:GE) is working with Preventice Solutions to give clinician tools to follow patients with known or suspected Atrial fibrillation virtually from hospital to home. Atrial fibrillation, or AF, is an irregular and often rapid heart rate that can increase risk of stroke, heart failure and other heart-related complications,... Read more
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) today announced it is one of 11 partners in the TIMID Consortium, a unique effort of six academic institutions and five life science and pharma companies that utilizes both mass cytometry and Imaging Mass Cytometry™ along with other technologies to explore the common cellular basis of... Read more